Sun domestic formulation spin-off plan offers scope for new alliances
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries' proposed spin-off of its domestic formulation operation to a wholly owned arm is expected to provide opportunities for independent collaboration and expansion of each of the businesses, without committing the existing organization in its 'entirety, the Indian firm informed shareholders.